Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding

NCT01434108 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Bleeding
Cirrhosis

Interventions

DRUG: Ornithine-phenylacetate

Sponsor

Hospital Universitari Vall d'Hebron Research Institute